ZA969412B - Tetracyclic 1,4-oxazine compounds a process for their preparation and pharmaceutical compositions containing them - Google Patents
Tetracyclic 1,4-oxazine compounds a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- ZA969412B ZA969412B ZA969412A ZA969412A ZA969412B ZA 969412 B ZA969412 B ZA 969412B ZA 969412 A ZA969412 A ZA 969412A ZA 969412 A ZA969412 A ZA 969412A ZA 969412 B ZA969412 B ZA 969412B
- Authority
- ZA
- South Africa
- Prior art keywords
- tetracyclic
- preparation
- pharmaceutical compositions
- compositions containing
- oxazine
- Prior art date
Links
- 150000004896 1,4-oxazines Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- YHWMFDLNZGIJSD-UHFFFAOYSA-N 2h-1,4-oxazine Chemical compound C1OC=CN=C1 YHWMFDLNZGIJSD-UHFFFAOYSA-N 0.000 abstract 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 abstract 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9513270A FR2741074B1 (fr) | 1995-11-09 | 1995-11-09 | Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA969412B true ZA969412B (en) | 1997-06-02 |
Family
ID=9484393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA969412A ZA969412B (en) | 1995-11-09 | 1996-11-08 | Tetracyclic 1,4-oxazine compounds a process for their preparation and pharmaceutical compositions containing them |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5733908A (de) |
| EP (1) | EP0773223B1 (de) |
| JP (1) | JPH09169770A (de) |
| CN (1) | CN1059443C (de) |
| AT (1) | ATE198752T1 (de) |
| AU (1) | AU709192B2 (de) |
| CA (1) | CA2189731C (de) |
| DE (1) | DE69611594T2 (de) |
| ES (1) | ES2155585T3 (de) |
| FR (1) | FR2741074B1 (de) |
| GR (1) | GR3035432T3 (de) |
| NO (1) | NO308132B1 (de) |
| NZ (1) | NZ299725A (de) |
| PT (1) | PT773223E (de) |
| ZA (1) | ZA969412B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| SK4782001A3 (en) | 1998-10-08 | 2001-11-06 | Smithkline Beecham Plc | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| BRPI0409492A (pt) * | 2003-04-18 | 2006-05-02 | Pharmacia & Up John Company Ll | terapias de combinação |
| FR2906249B1 (fr) | 2006-09-26 | 2008-12-19 | Servier Lab | Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3583307D1 (en) | 1984-05-10 | 1991-08-01 | Ciba Geigy Ag | Benzo-(pyrano und thiopyrano)-pyridine. |
| US4792548A (en) * | 1986-05-21 | 1988-12-20 | Warner-Lambert Company | Trans-benzopyran-(4,3-b)-1,4-oxazine derivatives, intermediates and pharmaceutical use |
| WO1993024471A1 (en) | 1992-06-02 | 1993-12-09 | Whitby Research, Inc. | Substituted naphthoxazines useful as dopaminergics |
| WO1994022495A1 (en) * | 1993-03-31 | 1994-10-13 | The Trustees Of The University Of Pennsylvania | Dopamine d-3 and serotonin (5-ht1a) receptor ligands and imaging agents |
| FR2721027B1 (fr) * | 1994-06-08 | 1996-07-19 | Adir | Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
-
1995
- 1995-11-09 FR FR9513270A patent/FR2741074B1/fr not_active Expired - Fee Related
-
1996
- 1996-11-05 NO NO964672A patent/NO308132B1/no unknown
- 1996-11-06 CA CA002189731A patent/CA2189731C/fr not_active Expired - Fee Related
- 1996-11-07 ES ES96402366T patent/ES2155585T3/es not_active Expired - Lifetime
- 1996-11-07 PT PT96402366T patent/PT773223E/pt unknown
- 1996-11-07 AT AT96402366T patent/ATE198752T1/de not_active IP Right Cessation
- 1996-11-07 JP JP8295025A patent/JPH09169770A/ja active Pending
- 1996-11-07 DE DE69611594T patent/DE69611594T2/de not_active Expired - Fee Related
- 1996-11-07 EP EP96402366A patent/EP0773223B1/de not_active Expired - Lifetime
- 1996-11-07 AU AU71704/96A patent/AU709192B2/en not_active Ceased
- 1996-11-08 CN CN96114534A patent/CN1059443C/zh not_active Expired - Fee Related
- 1996-11-08 NZ NZ299725A patent/NZ299725A/en unknown
- 1996-11-08 ZA ZA969412A patent/ZA969412B/xx unknown
- 1996-11-08 US US08/745,212 patent/US5733908A/en not_active Expired - Fee Related
-
2001
- 2001-02-20 GR GR20010400263T patent/GR3035432T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1156147A (zh) | 1997-08-06 |
| CN1059443C (zh) | 2000-12-13 |
| EP0773223B1 (de) | 2001-01-17 |
| DE69611594T2 (de) | 2001-08-09 |
| CA2189731C (fr) | 2002-04-09 |
| NO964672D0 (no) | 1996-11-05 |
| ES2155585T3 (es) | 2001-05-16 |
| ATE198752T1 (de) | 2001-02-15 |
| JPH09169770A (ja) | 1997-06-30 |
| PT773223E (pt) | 2001-06-29 |
| NZ299725A (en) | 1997-11-24 |
| NO964672L (no) | 1997-05-12 |
| NO308132B1 (no) | 2000-07-31 |
| FR2741074B1 (fr) | 1997-12-19 |
| AU7170496A (en) | 1997-05-15 |
| FR2741074A1 (fr) | 1997-05-16 |
| EP0773223A1 (de) | 1997-05-14 |
| DE69611594D1 (de) | 2001-02-22 |
| AU709192B2 (en) | 1999-08-26 |
| GR3035432T3 (en) | 2001-05-31 |
| CA2189731A1 (fr) | 1997-05-10 |
| US5733908A (en) | 1998-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8306141A1 (es) | Un procedimiento para la produccion de un derivado de carbostirilo | |
| HU9700992D0 (en) | New 3-(piperid-4-yl)1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUT59377A (en) | Process for producing drugs containing new aromatic rings | |
| DK0388309T3 (da) | Nye derivater af 1H,3H-pyrrolo(1,2-c)thiazol-7-carboxamid, deres fremstilling og farmaceutiske præparater med indhold deraf | |
| HU9400671D0 (en) | Benzoxazine derivatives and process for producing them and pharmaceutical compositions containing them | |
| GR3035432T3 (en) | Tetracyclic 1,4-oxazine compounds, process for their preparation and pharmaceutical compositions containing them | |
| DK0769296T3 (da) | Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer | |
| ES2069065T3 (es) | Nuevo derivado de hidroxilamina. | |
| ES8305359A1 (es) | Un procedimiento para la preparacion de benzamitas sustituidas. | |
| ATE229513T1 (de) | Disubstituierte trans-3,4,4a,5,6,10b-hexahydro-2h-napht(1,2-b)- ,4-oxazine, verfahren zu deren herstellung und diese enthaltende pharmazeutigsche zusammensetzungen | |
| ATE191483T1 (de) | Trizyklische oximether, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ZA954738B (en) | Tetracyclic piperidine and 1,4-oxazine compounds a process for their preparation and pharmaceutical compositions containing them | |
| IL102702A (en) | OPTICALLY ACTIVE g-HALO- 2-AMINOALKANECARBOXYLIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THEIR USE FOR THE PREPARATION OF OPTICALLY ACTIVE PHOSPHORUS-CONTAINING a-AMINO ACIDS | |
| TW349949B (en) | New imidazole derivatives, preparation process, intermediates obtained, use as medicaments, pharmaceutical compositions and new use | |
| ATE200780T1 (de) | Aminoalkyl benzothiazolinone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten | |
| AU4930797A (en) | New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| MX9707911A (es) | Derivados de amina 1-[w-(3,4-dihidro-2-naftalenil)alquil]- ciclica, proceso para su preparacion y composiciones farmaceuticas que contienen los mismos. |